Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $816,060 - $1.06 Million
134,000 Added 261.21%
185,300 $12,000
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $483,648 - $972,576
-105,600 Reduced 67.3%
51,300 $19,000
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $929,096 - $3.11 Million
131,600 Added 520.16%
156,900 $26,000
Q1 2022

May 12, 2022

SELL
$21.6 - $27.79 $632,880 - $814,247
-29,300 Reduced 53.66%
25,300 $21,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $471,500 - $594,705
20,500 Added 60.12%
54,600 $57,000
Q3 2021

Nov 10, 2021

SELL
$25.04 - $30.06 $22,536 - $27,054
-900 Reduced 2.57%
34,100 $59,000
Q2 2021

Aug 11, 2021

SELL
$27.43 - $32.7 $189,267 - $225,630
-6,900 Reduced 16.47%
35,000 $82,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $33.2 Million - $53.4 Million
-1,553,700 Reduced 97.37%
41,900 $257,000
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $393,467 - $542,784
25,700 Added 1.64%
1,595,600 $1.06 Million
Q3 2020

Nov 13, 2020

BUY
$14.88 - $20.13 $22.9 Million - $31 Million
1,542,100 Added 5547.12%
1,569,900 $684,000
Q2 2020

Aug 10, 2020

BUY
$13.31 - $20.51 $114,466 - $176,386
8,600 Added 44.79%
27,800 $14,000
Q1 2020

May 08, 2020

SELL
$12.98 - $30.25 $123,310 - $287,375
-9,500 Reduced 33.1%
19,200 $9,000
Q4 2019

Feb 11, 2020

SELL
$18.89 - $31.89 $3.79 Million - $6.39 Million
-200,400 Reduced 87.47%
28,700 $57,000
Q1 2019

May 10, 2019

SELL
$20.23 - $26.29 $4.48 Million - $5.82 Million
-221,400 Reduced 49.15%
229,100 $290,000
Q4 2018

Feb 12, 2019

BUY
$17.64 - $28.32 $7.56 Million - $12.1 Million
428,700 Added 1966.51%
450,500 $186,000
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $449,952 - $559,606
21,800 New
21,800 $60,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.